What is the best antibiotic (abx) for treating cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Antibiotic for Cellulitis

For typical uncomplicated cellulitis, use cephalexin (a first-generation cephalosporin) or dicloxacillin (a penicillinase-resistant penicillin) for 5-6 days, targeting streptococci as the primary pathogen. 1, 2

First-Line Therapy for Typical Cellulitis

  • Cephalexin (first-generation cephalosporin) is the preferred first-line agent with Grade A-I evidence from IDSA guidelines 2
  • Dicloxacillin (penicillinase-resistant semisynthetic penicillin) is an equally effective alternative with Grade A-I evidence 2
  • These agents target streptococci, which are the predominant pathogens in typical cellulitis without purulent drainage 1

Treatment Duration

  • A 5-6 day course is as effective as 10 days for uncomplicated cellulitis if clinical improvement occurs 1, 2
  • Extend treatment only if the infection has not improved within 5 days 1

When MRSA Coverage is NOT Needed

MRSA is an unusual cause of typical cellulitis and routine coverage is unnecessary 2. The evidence strongly supports this:

  • Two large randomized controlled trials showed that adding trimethoprim-sulfamethoxazole to cephalexin provided no benefit over cephalexin alone for uncomplicated cellulitis 3, 4
  • In the 2017 JAMA trial (n=496), clinical cure rates were 85.5% with cephalexin alone vs 83.5% with cephalexin plus TMP-SMX (no significant difference) 4

When to Add MRSA Coverage

Add MRSA-active antibiotics only in these specific high-risk scenarios: 1, 2

  • Penetrating trauma
  • Purulent drainage present
  • Evidence of MRSA infection elsewhere
  • Nasal colonization with MRSA documented
  • Injection drug use
  • Systemic inflammatory response syndrome (SIRS) present

MRSA Coverage Options (When Indicated)

Clindamycin 300-450 mg orally four times daily is the preferred single agent, as it covers both streptococci and MRSA 2, 5, 6

Alternative: Trimethoprim-sulfamethoxazole PLUS a β-lactam (cephalexin, penicillin, or amoxicillin) 2

For Penicillin/Cephalosporin Allergic Patients

  • Clindamycin is the preferred option, with 99.5% of S. pyogenes strains remaining susceptible 2, 5
  • For severe allergies requiring parenteral therapy, use vancomycin, linezolid, or telavancin 5

Route of Administration

  • Oral antibiotics are as effective as IV antibiotics for cellulitis of similar severity 7
  • Reserve IV therapy only for patients with SIRS, altered mental status, hemodynamic instability, or inability to take oral medications 1
  • Patients given oral-only therapy were more likely to have improved at day 5 compared to those given IV therapy in a 323-patient analysis 7

Critical Pitfall to Avoid

Do not routinely add MRSA coverage for typical cellulitis. This is the most common prescribing error. 2 Despite the prevalence of community-associated MRSA in purulent skin infections (abscesses), it remains an uncommon cause of non-purulent cellulitis. Two high-quality RCTs definitively showed no benefit from adding MRSA coverage to standard therapy for uncomplicated cellulitis 3, 4, yet clinicians continue to overprescribe MRSA-active agents.

Adjunctive Measures

  • Elevate the affected extremity to promote drainage of edema 1, 2, 5
  • Examine and treat interdigital toe spaces for tinea pedis, as this eradicates pathogen colonization and reduces recurrence 1, 2
  • Treat predisposing conditions including venous insufficiency, eczema, and edema 1, 2, 5
  • Consider systemic corticosteroids (prednisone 40 mg daily for 7 days) in non-diabetic adults to potentially hasten resolution 1, 2

Hospitalization Criteria

Admit patients with: 1, 5

  • SIRS or hemodynamic instability
  • Altered mental status
  • Concern for deeper or necrotizing infection
  • Severe immunocompromise
  • Failed outpatient therapy
  • Poor adherence anticipated

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Cellulitis of the Ear

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Recommendations for Cellulitis in Patients with Keflex Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.